John Friend, vice president and chief medical officer of Cellectar Biosciences (NASDAQ: [[ticker:CLRB]]), on Tuesday tendered his resignation from the company, Cellectar said in a regulatory filing. Friend’s last day is Nov. 27, according to the filing, which did not specify reasons for his departure. Madison, WI-based Cellectar is developing drugs with the potential to … Continue reading “Cellectar Announces Resignation of Chief Medical Officer John Friend”
Tag: Cellectar Biosciences
Packers, Cool Products, Cellectar & More: This Week’s WI Watchlist
Catch up on news from Wisconsin’s innovation community with these recent headlines: —The NFL’s Green Bay Packers said Craig Dickman has been named managing director of TitleTownTech, a joint venture between the team and Microsoft that’s aimed at spurring digital-age economic activity in northeastern Wisconsin. Dickman is the founder and former CEO of Breakthrough Fuel, … Continue reading “Packers, Cool Products, Cellectar & More: This Week’s WI Watchlist”
Hyperloop, Cellectar, Cheeks & More: This Week’s Wisconsin Watchlist
Keep up with news from Wisconsin’s innovation community with these recent headlines: —A team of students at the University of Wisconsin-Madison has constructed a third prototype for a vehicle designed to zoom through an above-ground vacuum tube at speeds that can exceed 300 miles per hour, the school said. The “Badgerloop” team is one of … Continue reading “Hyperloop, Cellectar, Cheeks & More: This Week’s Wisconsin Watchlist”
Venture Investors To Raise As Much As $100M To Fund Health Startups
Venture Investors plans to raise up to $100 million for a new, healthcare-focused venture capital fund, the Madison, WI-based firm said in a document recently filed with federal securities regulators. VI is the oldest and largest venture capital fund in Wisconsin. It created a new business entity, “Venture Investors Health Fund 6 Limited Partnership,” under … Continue reading “Venture Investors To Raise As Much As $100M To Fund Health Startups”
Doyenne, Epic, Cellectar, & More: This Week’s Wisconsin Watchlist
Keep up with news from Wisconsin’s innovation community with these recent headlines: —Doyenne Group, an organization that supports Wisconsin-based companies led by women and people of color, enrolled seven startups in its new business accelerator, the Wisconsin State Journal reported. The inaugural program reportedly kicked off in January and will run for 12 months. According … Continue reading “Doyenne, Epic, Cellectar, & More: This Week’s Wisconsin Watchlist”
Exact Sciences, Shine, Redox & More: This Week’s Wisconsin Watchlist
Keep up with the latest news from Wisconsin’s innovation community with these recent headlines: —Exact Sciences said it plans to raise up to $600 million through the sale of notes that can be converted into cash or shares of the company’s common stock, starting in 2025. Madison-based Exact (NASDAQ: [[ticker:EXAS]]) is developing several screening tests … Continue reading “Exact Sciences, Shine, Redox & More: This Week’s Wisconsin Watchlist”
Cellectar Biosciences Shutting Down Manufacturing Operations
Cellectar Biosciences has begun shutting down manufacturing operations at its headquarters and its plan going forward will be to have one of the company’s existing partners handle finished product manufacturing, Cellectar CEO Jim Caruso said Monday. Madison, WI-based Cellectar (NASDAQ: [[ticker:CLRB]]) is developing drugs with the potential to treat malignant tumors and certain forms of … Continue reading “Cellectar Biosciences Shutting Down Manufacturing Operations”
Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist
Keep up with the latest news from Wisconsin’s innovation community with these recent headlines: —The Scientist magazine named Fitchburg-based Promega’s “High BiT” protein-tagging system as one of its top 10 innovations of 2017. The product emits a bright light, allowing researchers to “quantify the abundance of a protein of interest, whether it be in the … Continue reading “Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist”
Gener8tor, Shine, Cellectar, & More: This Week’s Wisconsin Watchlist
Stay current on news from Wisconsin’s innovation community with these recent headlines: —Gener8tor announced the six startups chosen to receive investments and mentorship during its latest 12-week accelerator program, which kicked off last month and runs through November. The program is being run out of Gener8tor’s Milwaukee offices, and three of the companies in the … Continue reading “Gener8tor, Shine, Cellectar, & More: This Week’s Wisconsin Watchlist”
Epic, Zuckerberg, Cellectar, & More: This Week’s Wisconsin Watchlist
[Updated 5/3/17 9:53 a.m. See below.] Keep up with the latest news from Wisconsin’s innovation community, starting with these headlines: —The U.S. Coast Guard submitted a request for information to a government procurement website related to the purchase of electronic health records (EHR) software, Healthcare IT News reported. The Coast Guard had been installing EHR software … Continue reading “Epic, Zuckerberg, Cellectar, & More: This Week’s Wisconsin Watchlist”
Epic, UW Spinoffs, CDI, & More: This Week’s Wisconsin Watchlist
Stay current on news from Wisconsin’s innovation community, starting with these recent headlines: —The Capital Times published a lengthy profile of Judy Faulkner, founder and CEO of Verona-based Epic Systems. Epic develops software that healthcare organizations use to do everything from scheduling appointments to documenting information on patients in clinical settings to tracking the charges … Continue reading “Epic, UW Spinoffs, CDI, & More: This Week’s Wisconsin Watchlist”
Cellectar Brings On John Friend as Chief Medical Officer
Cellectar Biosciences, a Madison, WI-based company that is developing drugs with the potential to treat malignant tumors and certain forms of blood cancer, said on Wednesday that it has named John Friend as its chief medical officer, effective April 17. Friend, a physician, previously worked at the Swiss pharmaceutical group Helsinn Therapeutics for more than … Continue reading “Cellectar Brings On John Friend as Chief Medical Officer”
WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug
The organization that manages patents and licensing of intellectual property for the University of Wisconsin-Madison has expanded a licensing agreement with Cellectar Biosciences, a developer of cancer drugs, the company said earlier this week. The agreement, between the Wisconsin Alumni Research Foundation (WARF) and Madison, WI-based Cellectar (NASDAQ: [[ticker:CLRB]]), covers the use of the company’s … Continue reading “WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug”
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future
Cellectar Biosciences has seen ups and downs in the last 18 months, including several changes in its top ranks. Now, as the cancer drug developer prepares to take its lead drug candidate into mid-stage clinical trials, CEO Jim Caruso seems more interested in talking about his company’s future than its past. Madison, WI-based Cellectar (NASDAQ: … Continue reading “After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future”
Cellectar Awarded Another Cancer Drug Patent
[Updated 1/26/17, 1:15 pm. See below.] The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent on two cancer drugs the company is developing, including its lead drug candidate, according to the company. Madison, WI-based Cellectar (NASDAQ: [[ticker:CLRB]]) says the patent covers the use of its lead drug candidate, CLR 131, for treating … Continue reading “Cellectar Awarded Another Cancer Drug Patent”
Exact Sciences, Fiserv, OneEvent, & More: This Week’s WI Watchlist
Stay out of the snow, and in the know, with these recent headlines from Wisconsin’s innovation community. —Madison-based Exact Sciences (NASDAQ: [[ticker:EXAS]]) said that Cologuard, the company’s stool-based DNA test for colorectal cancer, will be covered as an in-network service for members of the Louisville, KY-based health insurer Humana (NYSE: [[ticker:HUM]]), effective Jan. 1. Cologuard … Continue reading “Exact Sciences, Fiserv, OneEvent, & More: This Week’s WI Watchlist”
Cellectar Announces $8M Stock Offering, Sending Shares Lower
Another day, another stock offering from Cellectar Biosciences. The Madison, WI-based biotech, which announced a $3.3 million stock offering in September 2015 and then said in April that it had raised $8 million from investors, now says it’s raising another $8 million in an offering that’s expected to close on Nov. 29. Cellectar’s pipeline includes … Continue reading “Cellectar Announces $8M Stock Offering, Sending Shares Lower”
Arrowhead, Microbes, Diabetes, & More: This Week’s WI Watchlist
Stay current on the latest happenings in Wisconsin’s innovation community with these headlines: —Arrowhead Pharmaceuticals, which is based in Pasadena, CA, but houses its R&D operations in Madison, WI, provided updates on some of its drug candidates and development programs at two recent industry conferences. At one of the meetings, Arrowhead (NASDAQ: [[ticker:ARWR]]) shared preclinical … Continue reading “Arrowhead, Microbes, Diabetes, & More: This Week’s WI Watchlist”
Cellectar Advances Drug Research With Pierre Fabre, Other Partners
Less than a year after Cellectar Biosciences announced a partnership with Pierre Fabre aimed at developing new cancer treatments, the collaboration appears to be bearing fruit. Madison, WI-based Cellectar (NASDAQ: [[ticker:CLRB]]) said Thursday that it has created multiple tumor-targeting compounds and has already started using them in a series of studies. The compounds were made … Continue reading “Cellectar Advances Drug Research With Pierre Fabre, Other Partners”
Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist
The 2016 presidential campaign is coming to a close and for many, not a day too soon. Renew your faith in humanity with these recent headlines from Wisconsin’s innovation community: —Madison-based Silatronix—a developer of silicon-based materials that can be used as electrolytes in batteries and other energy storage devices—was on a list of “10 Startups … Continue reading “Silatronix, Propeller, BrainXell, & More: This Week’s WI Watchlist”
UW-Madison Awarded $12M NCI Grant to Study Cellectar Cancer Drug
The National Cancer Institute has awarded a $12 million grant to the University of Wisconsin-Madison that the school will use to study Cellectar Biosciences’ leading drug candidate, the company said Monday. Cellectar (NASDAQ: [[ticker:CLRB]]), which is also located in Madison, said in a news release that the university will study CLR 131, a therapeutic Cellectar … Continue reading “UW-Madison Awarded $12M NCI Grant to Study Cellectar Cancer Drug”
Brookings Report, Imbed, & Coinigy: This Week’s Wisconsin Watchlist
Keep up with the latest news from Wisconsin’s innovation community with these recent headlines: —The Washington-based Brookings Institution released a report on trends in what the think tank calls “America’s advanced industries,” a group of 50 sectors with large numbers of STEM professionals. Madison, the 88th largest metropolitan area in the U.S. by population, was … Continue reading “Brookings Report, Imbed, & Coinigy: This Week’s Wisconsin Watchlist”
National Cancer Institute Awards Cellectar $2M For Clinical Study
Cellectar Biosciences has received a $2 million grant from the National Cancer Institute (NCI) that will support a Phase 2 clinical study of its leading drug candidate, the biotech company said earlier this week. Madison, WI-based Cellectar (NASDAQ: [[ticker:CLRB]]) said that the funding is aimed at advancing CLR 131, which has the potential to treat … Continue reading “National Cancer Institute Awards Cellectar $2M For Clinical Study”
Drones, Understory, & Cellectar: This Week’s Wisconsin Watchlist
Catch up on news from Wisconsin’s innovation community with these recent headlines: —Industries as diverse as insurance, agriculture, and construction are now using drones or considering it, the Wisconsin State Journal reported. The benefits to using these unmanned flying machines include worker productivity and safety, when it comes to tasks such as inspecting wind turbines. As … Continue reading “Drones, Understory, & Cellectar: This Week’s Wisconsin Watchlist”
Kiio, HealthTech Capitol, & Exact Sciences: This Week’s WI Watchlist
Power through the dog days of summer with these recent headlines from Wisconsin’s innovation community: —Madison-based Kiio raised $227,000 in debt financing from three investors, according to an SEC filing. Kiio is developing software-enabled bands that provide resistance during rehabilitative exercises and help physical therapists gauge the strength of patients. Founded in 2011, Kiio has … Continue reading “Kiio, HealthTech Capitol, & Exact Sciences: This Week’s WI Watchlist”
Cellectar Biosciences Co-founder Jamey Weichert Stepping Down
Jamey Weichert, co-founder and chief scientific officer of Cellectar Biosciences, will be leaving the company on July 15, Cellectar said in a document filed Thursday with the SEC. Madison, WI-based Cellectar (NASDAQ: [[ticker:CLRB]]) is seeking to commercialize cancer drugs and imaging agents that would be delivered to their targets by special compounds called phospholipid ethers. … Continue reading “Cellectar Biosciences Co-founder Jamey Weichert Stepping Down”
Exact Sciences, D2P, & Bon Ami: This Week’s Wisconsin Watchlist
Stay plugged in on news from Wisconsin’s innovation community with these recent headlines: —Even though a decision from the U.S. Preventive Services Task Force last month improved the outlook for Madison-based Exact Sciences (NASDAQ: [[ticker:EXAS]]) and Cologuard, its stool-based DNA test for colorectal cancer, there is still disagreement about whether insurance companies will cover the … Continue reading “Exact Sciences, D2P, & Bon Ami: This Week’s Wisconsin Watchlist”
Fred Lee, The UW Radiologist With Startup Vision
[Editor’s note: This is part of a series of stories on physicians at the University of Wisconsin Hospital and Clinics who have become full- or part-time entrepreneurs.] Fred Lee is not afraid to put himself out there. Lee is a radiologist at the University of Wisconsin Hospital and Clinics, where his primary area of interest … Continue reading “Fred Lee, The UW Radiologist With Startup Vision”
Redox, Cellectar, Shine, & PeptiMed: This Week’s Wisconsin Watchlist
Stay caught up on all the latest news from Wisconsin’s innovation community with these recent headlines: —Redox, a Madison-based startup whose software helps other developers integrate their products with electronic health records (EHR) systems used at hospitals and clinics, revealed some of the companies and health systems that are using or plan to use Redox’s … Continue reading “Redox, Cellectar, Shine, & PeptiMed: This Week’s Wisconsin Watchlist”
StartingBlock, Cellectar & 500 Startups: This Week’s WI Watchlist
—StartingBlock Madison, an entrepreneurial center that would be located within a proposed $69 million building project just east of the city’s downtown, no longer plans to feature Sector67 as an anchor tenant, the Wisconsin State Journal reported. Sector67, a maker space in Madison, reportedly decided it couldn’t agree to the terms of a contract it … Continue reading “StartingBlock, Cellectar & 500 Startups: This Week’s WI Watchlist”
Epic, OnKöl, Wicab, & ConjuGon: This Week’s Wisconsin Watchlist
An up-and-down week for Verona, WI-based healthtech giant Epic Systems highlights these recent headlines from the state’s innovation community: —The U.S. Coast Guard has pulled out of an agreement to install Epic’s electronic health records software, Politico reported. “The decision was driven by concerns about the project’s ability to deliver a viable product in a … Continue reading “Epic, OnKöl, Wicab, & ConjuGon: This Week’s Wisconsin Watchlist”
Wantable, Gener8tor, and Arrowhead: This Week’s Wisconsin Watchlist
A new biotech laboratory, another lofty national ranking for an accelerator, and changes to a coding school’s expansion plans are among these recent headlines from Wisconsin’s innovation community: —Milwaukee-based Wantable raised more than $2 million from investors, according to a regulatory filing. The startup ships curated boxes containing clothing, makeup, accessories, and other items to a … Continue reading “Wantable, Gener8tor, and Arrowhead: This Week’s Wisconsin Watchlist”
Phoenix, Baird’s New CEO, & Epic’s Growth: This Week’s WI Watchlist
Gyms are packed, forlorn Christmas trees lie on curbs, and the Green Bay Packers are in the NFL playoffs—it must be January in Wisconsin. Make it a resolution to stay plugged into the state’s innovation community, starting with these recent headlines: —Phoenix Nuclear Labs has raised $790,000 in debt financing, according to an SEC filing, … Continue reading “Phoenix, Baird’s New CEO, & Epic’s Growth: This Week’s WI Watchlist”
Cellular Dynamics, Epic, & Wellbe: This Week’s Wisconsin Watch List
Take a break from the hectic run-up to the holidays and check out these recent major headlines from Wisconsin’s innovation community: —A judge granted preliminary approval to a settlement in a class-action shareholder lawsuit against Madison-based Cellular Dynamics International, the Wisconsin State Journal reported. In April, CDI tentatively settled three similar lawsuits challenging the biotech’s $307 million sale … Continue reading “Cellular Dynamics, Epic, & Wellbe: This Week’s Wisconsin Watch List”
With Pierre Fabre Deal, Cellectar Shifts Strategy Under New CEO
Six months into his tenure as CEO of Cellectar Biosciences, Jim Caruso’s plan for retooling the business is taking shape. Having shelved its cancer diagnostics business, the Madison, WI-based biotech is going all-in on drugs and has found its first partner. Cellectar on Wednesday announced it will work with French drug company Pierre Fabre to develop … Continue reading “With Pierre Fabre Deal, Cellectar Shifts Strategy Under New CEO”
Wisconsin Roundup: Exact Sciences, Cellectar, BrightStar, & More
New funding, an office relocation, and a grant to develop a new drug are among the announcements we’re watching this week in Wisconsin’s tech and innovation community. Here are the details: —Exact Sciences (NASDAQ: [[ticker:EXAS]]) is set to move its headquarters to downtown Madison from the city’s west side after the Madison Common Council approved … Continue reading “Wisconsin Roundup: Exact Sciences, Cellectar, BrightStar, & More”
Shares in Cellectar Tumble After It Announces $3.3M Stock Offering
Cellectar Biosciences (NASDAQ: [[ticker:CLRB]]) expects to raise $3.3 million in a common stock offering, the Madison, WI-based biotech company said in a press release Monday. Shares in cash-strapped Cellectar, which CEO Jim Caruso said in an earnings call last month is open to collaborating with other companies across most of its drug pipeline, were lower on … Continue reading “Shares in Cellectar Tumble After It Announces $3.3M Stock Offering”
Wisconsin Roundup: Shoutlet, Cellectar, Cellular Dynamics & More
Here are some of the past week’s major headlines from Wisconsin’s tech and innovation community: —Madison-based Shoutlet was acquired by Austin, TX-based Spredfast, a fellow player in the social media management space, for an undisclosed sum. The Shoutlet brand will continue to exist and its headquarters will become the second largest development center for the … Continue reading “Wisconsin Roundup: Shoutlet, Cellectar, Cellular Dynamics & More”
Cellectar Biosciences Appoints New CEO Amid Recent Turmoil
Cellectar Biosciences today appointed a new president and CEO, the latest in a series of unexpected moves in recent weeks by the Madison, WI-based biotech company. Seasoned drug and device industry executive Jim Caruso is taking over for Simon Pedder, who resigned his positions as Cellectar CEO, president, and board director. The 54-year-old Pedder, who led the company since October … Continue reading “Cellectar Biosciences Appoints New CEO Amid Recent Turmoil”
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq
In a friendly IPO market for biotechs, going public the other way—reverse merging with a shell company—is understandably the path less trodden. But after a strategic reinvention, it was the best road forward for Lexington, MA-based Pulmatrix. Today, Pulmatrix will begin trading on the Nasdaq under the ticker symbol “PULM.” It’s completed a previously announced … Continue reading “After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq”
Wisconsin Roundup: Cellectar, Shine Medical, Concordia, & More
Before everyone checks out for the long weekend, here are a few recent headlines from Wisconsin’s innovation and technology community: —Madison-based Cellectar Biosciences (NASDAQ: [[ticker:CLRB]]) said in its latest quarterly earnings report that patient enrollment in its phase 2 clinical trial of one of its experimental cancer imaging agents is going slower than anticipated. The … Continue reading “Wisconsin Roundup: Cellectar, Shine Medical, Concordia, & More”
Wisconsin Roundup: Cellular Dynamics, Baird, Health Apps, & More
Here’s a collection of recent announcements from Wisconsin’s technology and innovation community: —Cellular Dynamics International (NASDAQ: [[ticker:ICEL]]) has reached a proposed settlement in three similar class-action lawsuits challenging the Madison-based company’s proposed $307 million sale to Tokyo-based Fujifilm, according to an SEC filing. The lawsuits alleged that Cellular Dynamics’s sale process was flawed and that … Continue reading “Wisconsin Roundup: Cellular Dynamics, Baird, Health Apps, & More”
Wisconsin Roundup: TermSync, Mpirik, Epic, Kiva, VictorySpark, & More
Here are a few of the latest headlines from Wisconsin’s innovation and technology community: —France-based Esker has acquired Fitchburg startup TermSync for an undisclosed amount. TermSync makes cloud-based accounts receivable software and previously raised $2.2 million from investors, SEC documents show. Esker’s U.S. headquarters are in Madison. —Milwaukee-based Mpirik snagged $1.75 million from investors to … Continue reading “Wisconsin Roundup: TermSync, Mpirik, Epic, Kiva, VictorySpark, & More”
Wisconsin Roundup: StudyBlue, Cellectar, 1 Million Cups, & More
Here are a few of the latest headlines in Wisconsin’s tech and innovation community: —Madison-based edtech startup StudyBlue tacked on about $438,000 to a funding round reported in June, bringing the total amount raised to more than $2.1 million, SEC filings show. The money came from previous investors, including Great Oaks Venture Capital, the Wisconsin … Continue reading “Wisconsin Roundup: StudyBlue, Cellectar, 1 Million Cups, & More”
Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers
Shifting perceptions and a cooling IPO market could lead more biotech startups to join a public stock exchange via a reverse merger with a shell company that is already publicly traded, says Organovo CEO Keith Murphy. That’s the route his San Diego-based company took in 2012, merging with a shell company whose stock was traded … Continue reading “Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers”
Wisconsin Roundup: Deltanoid, Cellectar, Startup Grind, ZBB, & More
Here’s a quick rundown of recent news from Wisconsin’s technology and innovation community: —Madison-based Deltanoid Pharmaceuticals announced top-line data from a Phase 2b clinical trial of its vitamin D-based drug, DP001, as a treatment for a hormonal imbalance that can occur in patients with chronic kidney disease. In a 12-week, double-blind, randomized, placebo-controlled study involving … Continue reading “Wisconsin Roundup: Deltanoid, Cellectar, Startup Grind, ZBB, & More”
Wisconsin Roundup: VictorySpark, Imbed, Virent, Cellectar, & More
There was a flurry of funding deals and new partnerships announced by Wisconsin startups and tech groups over the past week. Here’s a recap: —Madison-based Imbed Biosciences has raised about $683,000 from investors in a debt and equity funding round that could eclipse $1 million when closed, according to an SEC filing. The funding is … Continue reading “Wisconsin Roundup: VictorySpark, Imbed, Virent, Cellectar, & More”
Wisconsin Roundup: Exact Sciences, CSA Partners, 100state, & More
In this week’s installment of Wisconsin innovation headlines, startups are raising capital, co-working spaces are on the move, and a closely watched Madison life sciences company offers details about initial commercialization of its FDA-approved product: —Cellectar Biosciences (NASDAQ: [[ticker:CLRB]]) raised $13.5 million in its first public offering since moving to the Nasdaq stock exchange from … Continue reading “Wisconsin Roundup: Exact Sciences, CSA Partners, 100state, & More”
Cellectar Biosciences Makes Nasdaq Debut With $12.5M Stock Offering
Cellectar Biosciences, a Madison, WI-based startup developing cancer drugs and imaging tools, began trading on the Nasdaq stock exchange today and is holding a public stock offering expected to raise $12.5 million in cash. The announcement is a key step for the company, whose stock was traded over the counter. Xconomy recently explored Cellectar’s prospects … Continue reading “Cellectar Biosciences Makes Nasdaq Debut With $12.5M Stock Offering”
Wisconsin Roundup: Midwest Angel Investors, Epic, Cellectar, & More
Midwest investors flex their muscles, while Epic Systems faces stiffer competition in the electronic health records software space. Read on for details about these and other stories from the Wisconsin innovation scene. —The Great Lakes region accounted for 17.1 percent of angel investments in the first quarter, according to the latest Halo Report from Silicon … Continue reading “Wisconsin Roundup: Midwest Angel Investors, Epic, Cellectar, & More”